Dual-targeting of CD44 and CD133: a promising therapeutic strategy for glioblastoma treatment
Abstract The World Health Organization has classified glioblastoma as a grade IV tumor, the highest grade. Despite improvements in neurosurgery, chemotherapy, and radiation therapy, glioblastoma remains one of the most resistant tumors, and it consistently recurs. Glioblastoma cells that co-express...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SpringerOpen
2026-03-01
|
| Seri Bilgileri: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s41983-026-01141-0 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|